A Study of Utility of Pre-Myectomy Coronary Angiography in Hypertrophic Cardiomyopathy
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 16-009148
Sponsor Protocol Number: 16-009148
About this study
The purpose of this study is to assess patients with hypertrophic cardiomyopathy (HCM) undergoing first time sternotomy for septal myectomy without known coronary artery disease (CAD).
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Adult patients (age 20-79; age range chosen to allow ASCVD risk calculation) undergoing myectomy as first time sternotomy at Mayo Clinic Rochester for hypertrophic obstructive cardiomyopathy with pre-operative anatomic coronary definition (defined as CTA or coronary angiography)
Exclusion Criteria:
- Patients without pre-operative coronary angiogram or CT coronary angiogram at the time of myectomy
- Patients with prior symptoms or stress testing felt to be of high clinical probability for atherosclerotic coronary artery disease (to be determined on the basis of clinical note review)
- Patients with known CAD or coronary anatomy defined >1 year preceding myectomy
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Jeffrey Geske, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available